Boehringer Ingelheim revenue increased from €19.6 billion in 2018 to €21.3 billion in 2019, a (8.4%) increase.

Annual Revenue ()

Boehringer Ingelheim revenue was €21.27 b in FY, 2019 which is a (8.4%) year over year increase from the previous period.

FY, 2017FY, 2018FY, 2019
Revenue€21.19 b€19.63 b€21.27 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Boehringer Ingelheim revenue breakdown by business segment: 21.2% from Animal Health, 73.5% from Human Pharmaceuticals and 5.3% from Other

Boehringer Ingelheim revenue breakdown by geographic segment: 23.6% from Asia/Australia/Africa, 29.9% from Europe and 46.5% from Americas

FY, 2019FY, 2018FY, 2017
Discontinued Operations€174 m€205 m€813 m
Other sales€41 m€40 m€43 m
Biopharmaceuticals€786 m€734 m€678 m
Animal Health€4.04 b€3.96 b€3.9 b
Human Pharmaceuticals€13.96 b€12.56 b€12.62 b
FY, 2019FY, 2018FY, 2017
Asia/Australia/Africa€4.48 b€4.09 b€4.23 b
Americas€8.83 b€8.09 b€8.14 b
Europe€5.69 b€5.32 b€5.69 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu